+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global POC Molecular Diagnostics Market 2019-2023 - Product Image

Global POC Molecular Diagnostics Market 2019-2023

  • ID: 4721343
  • Report
  • December 2018
  • Region: Global
  • 138 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • bioMérieux
  • Bio-Rad Laboratories
  • Danaher
  • F. Hoffmann-La Roche
  • QIAGEN
  • MORE
Growing focus on technological advances to drive growth in the market. The increasing focus on the development of technologically advanced POC molecular diagnostic products will result in the augmented adoption of these products. These advanced devices decrease the workload of end-users and offer results within limited time. Therefore, to increase the efficiency and effectiveness of the results, the companies are developing advanced products. The analysts have predicted that the POC molecular diagnostics market will register a CAGR of almost 14% by 2023.

Market Overview

Growing number of M&A and collaborations

Large companies are increasingly acquiring and collaborating with specialized POC molecular diagnostic companies to expand their product portfolio. Collaboration would result in the development of additional POC tests which can be offered across the globe, thereby expanding the company’s reach.

Product recalls

End-users rely on companies that provide high-quality products. When products lead to patient injury or fatalities, manufacturers wither voluntarily recall them from the market. This affects the market growth and brand image.

For the detailed list of factors that will drive and challenge the growth of the POC molecular diagnostics market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Abbott and bioMérieux, the competitive environment is quite intense. Factors such as the growing number of M&A and collaborations and the growing focus on technological advances, will provide considerable growth opportunities to POC molecular diagnostics manufactures. Abbott, bioMérieux, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, and QIAGEN are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • bioMérieux
  • Bio-Rad Laboratories
  • Danaher
  • F. Hoffmann-La Roche
  • QIAGEN
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
  • Market segmentation by application
  • Comparison by application
  • Infectious diseases - Market size and forecast 2018-2023
  • Oncology - Market size and forecast 2018-2023
  • Hematology and endocrinology - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by application
PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY TECHNOLOGY
  • Market segmentation by technology
  • Comparison by technology
  • PCR (gene sequencing) - Market size and forecast 2018-2023
  • Microarray and hybridization - Market size and forecast 2018-2023
  • Market opportunity by technology
PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Growing focus on technological advances
  • Liquid biopsy as an emerging trend
  • Presence of government funding
PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • bioMérieux
  • Bio-Rad Laboratories
  • Danaher
  • F. Hoffmann-La Roche
  • QIAGEN
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Application - Market share 2018-2023 (%)
Exhibit 18: Comparison by application
Exhibit 19: Infectious diseases - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Infectious diseases - Year-over-year growth 2019-2023 (%)
Exhibit 21: Oncology - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Oncology - Year-over-year growth 2019-2023 (%)
Exhibit 23: Hematology and endocrinology - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Hematology and endocrinology - Year-over-year growth 2019-2023 (%)
Exhibit 25: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Others - Year-over-year growth 2019-2023 (%)
Exhibit 27: Market opportunity by application
Exhibit 28: Customer landscape
Exhibit 29: Technology - Market share 2018-2023 (%)
Exhibit 30: Comparison by technology
Exhibit 31: PCR (gene sequencing) market outlook
Exhibit 32: PCR (gene sequencing) - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: PCR (gene sequencing) - Year-over-year growth 2019-2023 (%)
Exhibit 34: Microarray and hybridization - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Microarray and hybridization - Year-over-year growth 2019-2023 (%)
Exhibit 36: Market opportunity by technology
Exhibit 37: Market share by geography 2018-2023 (%)
Exhibit 38: Geographic comparison
Exhibit 39: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in Americas
Exhibit 42: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 43: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 44: Top 3 countries in EMEA
Exhibit 45: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 46: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 47: Top 3 countries in APAC
Exhibit 48: Key leading countries
Exhibit 49: Market opportunity
Exhibit 50: M&A and collaborations: Market impact analysis
Exhibit 51: Product launch by companies
Exhibit 52: Product recalls
Exhibit 53: Impact of drivers and challenges
Exhibit 54: Vendor landscape
Exhibit 55: Landscape disruption
Exhibit 56: Vendors covered
Exhibit 57: Vendor classification
Exhibit 58: Market positioning of vendors
Exhibit 59: Abbott - Vendor overview
Exhibit 60: Abbott - Business segments
Exhibit 61: Abbott - Organizational developments
Exhibit 62: Abbott - Geographic focus
Exhibit 63: Abbott - Segment focus
Exhibit 64: Abbott - Key offerings
Exhibit 65: Abbott - Key customers
Exhibit 66: bioMérieux - Vendor overview
Exhibit 67: bioMérieux - Business segments
Exhibit 68: bioMérieux - Organizational developments
Exhibit 69: bioMérieux - Geographic focus
Exhibit 70: bioMérieux - Segment focus
Exhibit 71: bioMérieux - Key offerings
Exhibit 72: bioMérieux - Key customers
Exhibit 73: Bio-Rad Laboratories - Vendor overview
Exhibit 74: Bio-Rad Laboratories - Business segments
Exhibit 75: Bio-Rad Laboratories - Organizational developments
Exhibit 76: Bio-Rad Laboratories - Geographic focus
Exhibit 77: Bio-Rad Laboratories - Segment focus
Exhibit 78: Bio-Rad Laboratories - Key offerings
Exhibit 79: Bio-Rad Laboratories - Key customers
Exhibit 80: Danaher - Vendor overview
Exhibit 81: Danaher - Business segments
Exhibit 82: Danaher - Organizational developments
Exhibit 83: Danaher - Geographic focus
Exhibit 84: Danaher - Segment focus
Exhibit 85: Danaher - Key offerings
Exhibit 86: Danaher - Key customers
Exhibit 87: F. Hoffmann-La Roche - Vendor overview
Exhibit 88: F. Hoffmann-La Roche - Business segments
Exhibit 89: F. Hoffmann-La Roche - Organizational developments
Exhibit 90: F. Hoffmann-La Roche - Geographic focus
Exhibit 91: F. Hoffmann-La Roche - Segment focus
Exhibit 92: F. Hoffmann-La Roche - Key offerings
Exhibit 93: F. Hoffmann-La Roche - Key customers
Exhibit 94: QIAGEN - Vendor overview
Exhibit 95: QIAGEN - Product segments
Exhibit 96: QIAGEN - Organizational developments
Exhibit 97: QIAGEN - Geographic focus
Exhibit 98: QIAGEN - Segment focus
Exhibit 99: QIAGEN - Key offerings
Exhibit 100: QIAGEN - Key customers
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott
  • bioMérieux
  • Bio-Rad Laboratories
  • Danaher
  • F. Hoffmann-La Roche
  • QIAGEN
  • MORE
Global POC Molecular Diagnostics Market 2019-2023

The analyst recognizes the following companies as the key players in the global POC molecular diagnostics market: Abbott, bioMérieux, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, and QIAGEN.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the growing focus on technological advances.”

According to the report, one of the major drivers for this market is the growing number of M&A and collaborations.

Further, the report states that one of the major factors hindering the growth of this market is the product recalls.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott
  • bioMérieux
  • Bio-Rad Laboratories
  • Danaher
  • F. Hoffmann-La Roche
  • QIAGEN
Note: Product cover images may vary from those shown
Adroll
adroll